TITLE

Continuing Education Case Study Quiz

PUB. DATE
February 2008
SOURCE
Hospital Pharmacy;Feb2008, Vol. 43 Issue 2, p133
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A quiz about the use of raltegravir to treat HIV infection is presented.
ACCESSION #
29976258

 

Related Articles

  • Raltegravir may be effective for adolescents with HIV.  // Infectious Diseases in Children;Oct2009, Vol. 22 Issue 10, p50 

    The article focuses on a study which examined the efficacy and safety of raltegravir in adolescents with human immunodeficiency virus (HIV) infection.

  • Early zidovudine treatment for patients with HIV infection.  // American Family Physician;12/1/1995, Vol. 52 Issue 8, p2358 

    Reports on a study on the use of early zidovudine treatment in asymptomatic patients with HIV infections in the United States, as presented in the August 17, 1995 issue of `New England Journal of Medicine.' Comparison between immediate and deferred zidovudine treatment; Effectiveness of...

  • Starting Medication for HIV/AIDS.  // American Family Physician;8/1/1996, Vol. 54 Issue 2, p587 

    Presents answers to various queries related to the medication for HIV infections. Overview of the effectiveness medicines for HIV infections to stop the growth of HIV virus; Information on generic as well as trade names of medicines for HIV infections; Sources of information about HIV treatment.

  • This way up. Seife, Charles // New Scientist;04/11/98, Vol. 158 Issue 2129, p14 

    Reports that only one of the two ways that the drug zidovudine (AZT) interacts with the human immunodeficiency virus (HIV) is active against the virus. Possibility of new drugs resulting from the research.

  • The morning after.  // Heart & Soul;Sep/Oct98, Issue 29, p24 

    Reports on the use of post-exposure therapy (PET) to treat health care workers accidentally exposed to HIV. Effectiveness of the AIDS drug AZT; Drawbacks of using PET.

  • Treatment of Human Immunodeficiency Virus Infection with Hydroxyurea, Didanosine, and a Protease Inhibitor before Seroconversion Is Associated with Normalized Immune Parameters and Limited Viral Reservoir. Lori, Franco; Jessen, Heiko; Lieberman, Judy; Finzi, Diana; Rosenberg, Eric; Tinelli, Carmine; Walker, Bruce; Siliciano, Robert F. // Journal of Infectious Diseases;12/1/99, Vol. 180 Issue 6, p1827 

    Current treatments for human immunodeficiency virus (HIV) require uninterrupted drug administration because they are unable to reconstitute the immune response and do not affect the viral reservoir. Ten patients were treated during acute HIV infection before complete Western blot (WB)...

  • Criticisms of Concorde dominate AIDS conference. Roberts, John // BMJ: British Medical Journal (International Edition);6/19/93, Vol. 306 Issue 6893, p1631 

    Assesses the efficacy of zidovudine for the treatment of HIV in Great Britain. Influence of the drug in the daily onset of AIDS; Increase in the CD4 counts of patients; Adverse effects of zidovudine.

  • Double agent.  // New Scientist;9/30/95, Vol. 147 Issue 1997, p12 

    Reports that people with HIV survive longer if they are treated with a combination of two antiviral drugs instead of one. Decline in the death rate of patients who received combination therapy.

  • Interleukin-2 therapy in HIV infection. Pahwa, Savita; Morales, Maripaz // AIDS Patient Care & STDs;Mar1998, Vol. 12 Issue 3, p187 

    Examines the use of interleukin-2 (IL-2) therapy in patients infected with human immunodeficiency virus (HIV). Identification of the role of cytokines in the immune system; Use of interleukin in cancer therapy; Description of mechanisms of IL-2.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics